These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6269824)

  • 1. Potential value of cefoperazone in bacterial meningitis: experimental studies.
    Durack DT; Perfect JR
    Drugs; 1981; 22 Suppl 1():60-4. PubMed ID: 6269824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
    McCracken GH; Nelson JD; Grimm L
    Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis.
    Perfect JR; Durack DT
    J Antimicrob Chemother; 1981 Jul; 8(1):49-58. PubMed ID: 6265429
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
    Schaad UB; McCracken GH; Loock CA; Thomas ML
    J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.
    Nolan CM; Ulmer C
    Rev Infect Dis; 1982; 4 Suppl():S396-400. PubMed ID: 6294789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis.
    Thirumoorthi MC; Buckley JA; Aravind MK; Kauffman RE; Dajani AS
    J Pediatr; 1981 Dec; 99(6):975-9. PubMed ID: 6458673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis.
    Modai J; Wolff M; Lebas J; Meulemans A; Manuel C
    Antimicrob Agents Chemother; 1982 Apr; 21(4):551-3. PubMed ID: 6211136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of moxalactam in the treatment of meningitis: efficacy and meningeal diffusion].
    Fosse T; Raoult D; David MF; Garnier JM; Arnolds M; Gallais H; Giraud F
    Pathol Biol (Paris); 1983 Jun; 31(6):477-9. PubMed ID: 6224124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.
    Kaplan SL; Mason EO; Garcia H; Kvernland SJ; Loiselle EM; Anderson DC; Mintz AA; Feigin RD
    J Pediatr; 1981 Jan; 98(1):152-7. PubMed ID: 6450278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drugs for enteric gram-negative bacillary meningitis in adults.
    Med Lett Drugs Ther; 1981 Aug; 23(17):73-4. PubMed ID: 6267438
    [No Abstract]   [Full Text] [Related]  

  • 11. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
    Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
    Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
    Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of newer cephalosporins into cerebrospinal fluid.
    Cherubin CE; Eng RH; Norrby R; Modai J; Humbert G; Overturf G
    Rev Infect Dis; 1989; 11(4):526-48. PubMed ID: 2672238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
    Greenfield RA; Kurzynski TA; Craig WA
    Antimicrob Agents Chemother; 1982 May; 21(5):846-7. PubMed ID: 6285817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
    Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
    Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of moxalactam for gram-negative and Haemophilus influenzae meningitis: an appraisal.
    Dillon HC
    J Pediatr; 1981 Dec; 99(6):907-8. PubMed ID: 6458672
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Presse Med; 1983 Jan; 12(3):139-42. PubMed ID: 6220351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.